US Drug Enforcement Concerned About Canada’s Fentanyl ‘Super Laboratories’

US Drug Enforcement Concerned About Canada’s Fentanyl ‘Super Laboratories’
A DEA logo at the Office of the US Drug Enforcement Administration (DEA) on May 29, 2019 in New York City. JOHANNES EISELE/AFP via Getty Images
Noé Chartier
Updated:
0:00

The U.S. Drug Enforcement Administration (DEA) is highly focused on Mexican cartels in its latest national threat assessment, but it also raises concerns about Canada, citing the presence of large-scale, sophisticated fentanyl laboratories in the country.

The DEA released on May 13 its National Drug Threat Assessment for the year 2025, which identifies the key Mexican cartels and their operations, and provides an overview of the trends involving the different types of narcotics found in the United States.